The Biden administration proposed a rule on Nov. 26 for Medicare and Medicaid to cover anti-obesity medications that were designed to prevent the development of Type 2 diabetes.
More than 42 percent of American adults and 19 percent of children struggle with obesity, which is now recognized as a chronic, life-threatening disease, according to the National Institutes of Health. Obesity can lead to diabetes, cardiovascular disease, stroke, cancer, and other medical emergencies.
The drugs—which include injectable medications such as Wegovy, Zepbound, and Ozempic—can reduce deaths and sickness from heart attacks and other cardiovascular ailments by upward of 20 percent, according to a study in the New England Journal of Medicine….